(Q39845389)

15 September 2017

title

Proliferative effect of Apidra (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cells (English)

1 reference

15 September 2017

1 reference

Ashish Shukla

1

1 reference

15 September 2017

Harald Enzmann

series ordinal

2

1 reference

15 September 2017

Doris Mayer

series ordinal

3

1 reference

15 September 2017

publication date

1 July 2009

1 reference

Archives of Physiology and Biochemistry

15 September 2017

published in

1 reference

15 September 2017

volume

115

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

119-126

1 reference

Insulin glulisine complementing basal insulins: a review of structure and activity

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

IGF and insulin receptor signaling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin analogs with improved pharmacokinetic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin aspart: a novel rapid-acting human insulin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Adaptive character of liver glucokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin-like growth factors and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Microheterogeneity of cytosolic and membrane-bound hexokinase II in Morris hepatoma 3924A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin glulisine--a comprehensive preclinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13813450903008628

10.1080/13813450903008628

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference